1. Home
  2. BTZ vs EVO Comparison

BTZ vs EVO Comparison

Compare BTZ & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Credit Allocation Income Trust

BTZ

BlackRock Credit Allocation Income Trust

HOLD

Current Price

$10.06

Market Cap

998.6M

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.00

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTZ
EVO
Founded
2006
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
998.6M
934.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BTZ
EVO
Price
$10.06
$3.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
272.3K
85.0K
Earning Date
01-01-0001
04-08-2026
Dividend Yield
9.40%
N/A
EPS Growth
N/A
N/A
EPS
1.41
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
$7.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.70
$2.31
52 Week High
$11.18
$4.48

Technical Indicators

Market Signals
Indicator
BTZ
EVO
Relative Strength Index (RSI) 42.51 53.04
Support Level $9.70 $2.88
Resistance Level $10.42 $3.36
Average True Range (ATR) 0.09 0.09
MACD -0.03 -0.01
Stochastic Oscillator 39.81 54.34

Price Performance

Historical Comparison
BTZ
EVO

About BTZ BlackRock Credit Allocation Income Trust

Blackrock Credit Allocation Income Trust is a diversified, closed-end Trust engaged in providing investment advisory and risk management solutions. Its investment objective is to seek current income, current gains, and capital appreciation. The company invests under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment-grade corporate bonds, high-yields, bank loans, preferred securities or convertible bonds, or derivatives with economic characteristics similar to these credit-related securities.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: